Back to Menu
Kidney cancer is a malignant tumor originating from renal tubular epithelial cells. As a common malignancy of the urinary system, its incidence shows geographic variation worldwide. Kidney cancer is highly heterogeneous with diverse clinical presentations and may metastasize distantly at an early stage. Diagnosis requires an integrated approach including imaging, histopathology, and molecular testing.
1. Clear cell renal cell carcinoma
The most common type (70%–80%), arising from proximal tubular epithelium. Tumor cells have clear cytoplasm and are closely associated with VHL gene alterations.
2. Papillary renal cell carcinoma
The second most common type (10%–15%), characterized by papillary architecture. It includes type I (more favorable prognosis) and type II (more aggressive).
3. Chromophobe renal cell carcinoma
Accounts for 5%–10%, arising from the collecting duct system. Cells are large with perinuclear halos, and prognosis is generally better than other subtypes.
4. Collecting duct carcinoma (Bellini duct carcinoma)
Rare (<1%), arising from the Bellini ducts. Highly aggressive, often metastatic at diagnosis, with a very poor prognosis.
5. Renal medullary carcinoma
Extremely rare, seen almost exclusively in patients with sickle cell trait. Rapid growth with early metastasis and an extremely poor prognosis.
1. Smoking and obesity
Smoking increases risk by ~50%. Obesity promotes risk via hormonal and inflammatory pathways, jointly increasing susceptibility to kidney cancer.
2. Hypertension and medications
Long-standing hypertension and certain antihypertensive agents may increase risk, potentially via altered renal perfusion and tubular injury.
3. Occupational exposure and chemicals
Exposure to asbestos, cadmium, and organic solvents may increase risk. These substances can accumulate during renal metabolism and cause chronic tubular damage.
4. Genetic factors
Hereditary disorders such as VHL syndrome and related gene mutations are associated with early-onset kidney cancer and are often multifocal.
5. End-stage kidney disease
Long-term dialysis can lead to acquired cystic kidney disease, markedly increasing kidney cancer risk and often presenting as multicentric disease.
1. Avoid risk factors
Smoking cessation is the most effective preventive measure. Control body weight and reduce exposure to hazardous chemicals.
2. Healthy dietary habits
Increase fruit and vegetable intake, reduce high-fat/high-protein foods, control blood pressure and glucose, and maintain adequate hydration.
3. Regular health examinations and screening
High-risk populations should undergo periodic abdominal ultrasonography. Seek medical attention promptly for painless hematuria or flank pain.
4. Chronic disease management
Actively control hypertension and diabetes. Patients on long-term dialysis should undergo regular imaging surveillance for renal changes.
5. Genetic counseling and testing
Individuals with a family history or early-onset kidney cancer may consider genetic counseling to develop personalized screening strategies.
6. Psychological adjustment and support
Maintain a positive mindset to cope with stress, and consider support groups to improve psychological well-being and quality of life.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that kidney cancer is a common malignancy, and early diagnosis with standardized treatment is key to improving cure rates. Advances in targeted therapy, immunotherapy, and minimally invasive techniques continue to improve outcomes. The public should remain vigilant for symptoms, undergo regular health examinations, adopt healthy lifestyle practices, and avoid risk factors.
Kidney cancer is a malignant tumor originating from renal tubular epithelial cells. As a common malignancy of the urinary system, its incidence shows geographic variation worldwide. Kidney cancer is highly heterogeneous with diverse clinical presentations and may metastasize distantly at an early stage. Diagnosis requires an integrated approach including imaging, histopathology, and molecular testing.
1. Clear cell renal cell carcinoma
The most common type (70%–80%), arising from proximal tubular epithelium. Tumor cells have clear cytoplasm and are closely associated with VHL gene alterations.
2. Papillary renal cell carcinoma
The second most common type (10%–15%), characterized by papillary architecture. It includes type I (more favorable prognosis) and type II (more aggressive).
3. Chromophobe renal cell carcinoma
Accounts for 5%–10%, arising from the collecting duct system. Cells are large with perinuclear halos, and prognosis is generally better than other subtypes.
4. Collecting duct carcinoma (Bellini duct carcinoma)
Rare (<1%), arising from the Bellini ducts. Highly aggressive, often metastatic at diagnosis, with a very poor prognosis.
5. Renal medullary carcinoma
Extremely rare, seen almost exclusively in patients with sickle cell trait. Rapid growth with early metastasis and an extremely poor prognosis.
1. Smoking and obesity
Smoking increases risk by ~50%. Obesity promotes risk via hormonal and inflammatory pathways, jointly increasing susceptibility to kidney cancer.
2. Hypertension and medications
Long-standing hypertension and certain antihypertensive agents may increase risk, potentially via altered renal perfusion and tubular injury.
3. Occupational exposure and chemicals
Exposure to asbestos, cadmium, and organic solvents may increase risk. These substances can accumulate during renal metabolism and cause chronic tubular damage.
4. Genetic factors
Hereditary disorders such as VHL syndrome and related gene mutations are associated with early-onset kidney cancer and are often multifocal.
5. End-stage kidney disease
Long-term dialysis can lead to acquired cystic kidney disease, markedly increasing kidney cancer risk and often presenting as multicentric disease.
1. Avoid risk factors
Smoking cessation is the most effective preventive measure. Control body weight and reduce exposure to hazardous chemicals.
2. Healthy dietary habits
Increase fruit and vegetable intake, reduce high-fat/high-protein foods, control blood pressure and glucose, and maintain adequate hydration.
3. Regular health examinations and screening
High-risk populations should undergo periodic abdominal ultrasonography. Seek medical attention promptly for painless hematuria or flank pain.
4. Chronic disease management
Actively control hypertension and diabetes. Patients on long-term dialysis should undergo regular imaging surveillance for renal changes.
5. Genetic counseling and testing
Individuals with a family history or early-onset kidney cancer may consider genetic counseling to develop personalized screening strategies.
6. Psychological adjustment and support
Maintain a positive mindset to cope with stress, and consider support groups to improve psychological well-being and quality of life.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that kidney cancer is a common malignancy, and early diagnosis with standardized treatment is key to improving cure rates. Advances in targeted therapy, immunotherapy, and minimally invasive techniques continue to improve outcomes. The public should remain vigilant for symptoms, undergo regular health examinations, adopt healthy lifestyle practices, and avoid risk factors.